Whalesbook
National Oxygen Limited announced its Board of Directors has approved a preferential issue of up to 9,50,000 equity shares, each with a face value of INR 10, to Saraf Housing Development Private Limited, an entity within the company's promoter group. This move is aimed at raising capital and could strengthen the promoter's stake. A registered valuer has been appointed to determine the share issue price according to SEBI regulations.
Board Approves Share Issue
The company's Board of Directors, during its meeting on March 20, 2026, granted in-principle approval for the preferential issue. The shares will be allotted to Saraf Housing Development Private Limited. To comply with SEBI regulations, a registered valuer has been appointed to determine the specific issue price.
Why This Matters
This allotment serves as a method for National Oxygen to raise capital, potentially bolstering its financial standing. It also aims to consolidate the promoter group's shareholding, which could increase their control. Public shareholders might see this as a positive capital injection or face stake dilution if the shares are issued at a significant discount to market prices.
Past Share Issues and Promoter Holdings
National Oxygen, a maker of industrial gases, has previously engaged in preferential share issuances to its promoters. In April 2024, listing approval was granted for 2,40,114 equity shares issued to a promoter at a ₹120 premium. Earlier, approval was given for up to 2,50,000 shares at ₹100 each to Saraf Housing Development Private Limited. As of March 2025, the promoter group held approximately 70.16% of the company, with Saraf Housing Development Private Limited owning about 9.78%. Despite these actions, the company has reported recent quarterly losses and a negative book value per share.
Key Changes Ahead
- Increased Promoter Stake: The promoter group's overall shareholding percentage is expected to rise following this issue.
- Capital Infusion: Proceeds from the issue may support operational needs or future expansion, aligned with company strategy.
- Potential Dilution: Public shareholders' stakes could be diluted if the issue price is significantly lower than current market valuations.
- Shareholding Structure: The company's ownership structure will change after the shares are allotted.
Risks to Watch
- Financial Performance: The company's history of losses and negative book value per share might affect how effectively new capital is used.
- Valuation and Price Discovery: The final issue price is crucial; a substantial discount could concern minority shareholders.
- Market Volatility: Previous stock price movements have led to clarification requests from the BSE.
- Promoter Selling: Reports indicate that promoters have been selling shares on the open market, which could negatively impact sentiment.
Peer Comparison
National Oxygen competes in the industrial gases sector with larger companies such as Linde India Ltd. and Ellenbarrie Industrial Gases Ltd. Linde India has a market capitalization of approximately ₹59,797 crore and a PE ratio of 131.5. Ellenbarrie Industrial Gases has a market cap of about ₹2,864 crore and a PE of 34.4. In contrast, National Oxygen has a much smaller market capitalization of around ₹33 crore, a PE of 32.29, and faces challenges from its negative book value and recent quarterly losses, underscoring its distinct financial position within the industry.
Latest Financial Snapshot
National Oxygen Limited reported a net loss of ₹1.55 crore for the quarter ending December 2025.
What to Watch For
- The final issue price determined by the registered valuer.
- Securing necessary regulatory approvals from SEBI and stock exchanges.
- The total funds raised and their planned use by the company.
- The updated shareholding pattern announcement following the allotment.
- Future financial results and overall operational performance.